PGI14 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE- SHOULD EMERGING SAFETY CONCERNS AFFECT THERAPEUTIC DECISION-MAKING?
Abstract
Authors
PB Ryan AK Biddle
PB Ryan AK Biddle
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now